However, Bar et al., in 2007 showed higher expression of GLI1 in 5 out of 19 GBM cases (26%) and found good correlation with SHH ligand expression in these samples suggesting ligand-driven activity of Hh-pathway [25]. The gene discussed is SHH; the disease is glioblastoma.